Related Experiment Video

Updated: Aug 8, 2026

Establishment of Human Epithelial Enteroids and Colonoids from Whole Tissue and Biopsy
06:33

Establishment of Human Epithelial Enteroids and Colonoids from Whole Tissue and Biopsy

Published on: March 6, 2015

Transforming growth factor-beta 1 inhibits cyclin D1 expression in intestinal epithelial cells

T C Ko1, H M Sheng, D Reisman

  • 1Department of Surgery, University of Texas Medical Branch, Galveston 77555.

Oncogene
|January 5, 1995
PubMed

Insights

Transforming growth factor-beta 1 (TGF-beta 1) inhibits intestinal epithelial cell growth by blocking the cell cycle. This occurs through the suppression of cyclin D1, a key regulator of cell cycle progression.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Transforming growth factor-beta 1 (TGF-beta 1) is known to inhibit epithelial cell proliferation.
  • Cyclin D proteins (D1, D2, D3) and cyclin-dependent kinase 4 (Cdk4) are critical regulators of the G1 phase of the cell cycle.

Purpose of the Study:

  • To investigate the effects of TGF-beta 1 on cell cycle progression and the expression of D cyclins and Cdk4 in rat intestinal epithelial cells (IEC-6 and RIE-1).
  • To determine the specific role of cyclin D1 in TGF-beta 1-mediated cell cycle inhibition.

Main Methods:

  • Treatment of exponentially growing and G0-synchronized IEC-6 and RIE-1 cells with TGF-beta 1.
  • Measurement of DNA synthesis, cell cycle progression, and expression levels of cyclin D1, D2, D3, and Cdk4 mRNA and protein.

Main Results:

  • TGF-beta 1 treatment blocked DNA synthesis and suppressed cyclin D1 mRNA and protein expression in both cell lines.
  • Levels of cyclins D2, D3, and Cdk4 remained largely unchanged following TGF-beta 1 treatment.
  • In G0-synchronized cells, TGF-beta 1 inhibited G1 progression by suppressing cyclin D1 protein, while cyclin D3 levels were unaffected.

Conclusions:

  • Cyclin D/Cdk4 is a critical target of TGF-beta 1 in intestinal epithelial cells.
  • TGF-beta 1 regulates the cyclin D/Cdk4 complex primarily through the modulation of cyclin D1 expression.

More Related Videos

3D Culturing of Organoids from the Intestinal Villi Epithelium Undergoing Dedifferentiation06:40

3D Culturing of Organoids from the Intestinal Villi Epithelium Undergoing Dedifferentiation

Published on: April 1, 2021

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...